Full year results 2010
Toumaz Limited (AIM: TMZ, ‘Toumaz’), a pioneer in low cost, ultra-low power wireless communications technology, announces its full year results for the year ended 31 December 2010.
Highlights
· Development of the ultra-low power Sensium™ ‘digital plaster’ wireless monitoring system; on schedule for completion in H1 2011 and clinical trials successfully completed in US and UK
· Key strategic investment from and partnership with Quanta Computing Inc (‘Quanta’) to develop low power wireless healthcare and wellness technology for outside the hospital environment
· Successful launch of Xenif all-in-one DAB, FM, Wi-Fi baseband processor chip
· Year-end cash position £2.9m
· Successful launch of Telran in January 2011 – the world’s lowest power radio chip
· Strategic investment by and partnership with California Capital Equity (CCE), a company owned by Dr. Patrick Soon-Shiong, to develop the Sensium for use in North American sports markets, in February 2011
Professor Chris Toumazou, Chief Executive of Toumaz, commented,
“This is an exciting time for Toumaz as we now have completed products and are entering a commercial launch period. In particular the Sensium ‘digital plaster’ has been submitted for medical approval and will be launched later this year.
“Other key highlights are the new relationship with Dr Patrick Soon-Shiong, who has recognised the potential for distribution of the Sensium for consumer health into the US markets and the widening relationship with Quanta, who will be launching a Sensium-based diabetes monitor for Asian markets later this year. Both have also taken a stake in Toumaz.
“Our Xenif all-in-one DAB, FM and Wi-Fi based processor chip and Telran, the world’s lowest power radio chip have also made good progress with the former already securing a tier one customer.”
Enquiries:
Toumaz Limited |
020 7355 0036 |
Chris Toumazou, Chief Executive Officer |
|
Patrick Stephansen, Chief Financial Officer |
|
FinnCap |
020 7600 1658 |
Charles Cunningham (Corporate Finance) |
|
Brian Patient (Corporate Broking) |
|
College Hill |
020 7457 2020 |
Adrian Duffield/Rozi Morris |